Your browser doesn't support javascript.
loading
Roles of PIKfyve in multiple cellular pathways.
Rivero-Ríos, Pilar; Weisman, Lois S.
Afiliación
  • Rivero-Ríos P; Life Sciences Institute and Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
  • Weisman LS; Life Sciences Institute and Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, USA. Electronic address: lweisman@umich.edu.
Curr Opin Cell Biol ; 76: 102086, 2022 06.
Article en En | MEDLINE | ID: mdl-35584589
ABSTRACT
Phosphoinositide signaling lipids are crucial for eukaryotes and regulate many aspects of cell function. These signaling molecules are difficult to study because they are extremely low abundance. Here, we focus on two of the lowest abundance phosphoinositides, PI(3,5)P2 and PI(5)P, which play critical roles in cellular homeostasis, membrane trafficking and transcription. Their levels are tightly regulated by a protein complex that includes PIKfyve, Fig4 and Vac14. Importantly, mutations in this complex that decrease PI(3,5)P2 and PI(5)P are linked to human diseases, especially those of the nervous system. Paradoxically, PIKfyve inhibitors which decrease PI(3,5)P2 and PI(5)P, are currently being tested for some neurodegenerative diseases, as well as other diverse diseases including some cancers, and as a treatment for SARS-CoV2 infection. A more comprehensive picture of the pathways that are regulated by PIKfyve will be critical to understand the roles of PI(3,5)P2 and PI(5)P in normal human physiology and in disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfatos de Fosfatidilinositol / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Curr Opin Cell Biol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfatos de Fosfatidilinositol / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Curr Opin Cell Biol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos